Green day on Tuesday for Catalyst Pharmaceuticals stock after gaining 2.02%
(Updated on Dec 07, 2021)

The Catalyst Pharmaceuticals stock price gained 2.02% on the last trading day (Tuesday, 7th Dec 2021), rising from $6.93 to $7.07. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 5.92% from a day low at $6.76 to a day high of $7.16. The price has risen in 6 of the last 10 days, but is still down by -2.75% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 456 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $8.48 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 47.88% during the next 3 months and, with a 90% probability hold a price between $10.10 and $11.81 at the end of this 3-month period.

Signals & Forecast

The Catalyst Pharmaceuticals stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.96 and $6.64. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 17, 2021, and so far it has fallen -5.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Catalyst Pharmaceuticals finds support from accumulated volume at $6.86 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.40 between high and low, or 5.92%. For the last week, the stock has had a daily average volatility of 4.78%.

Our recommended stop-loss: $6.73 (-4.79%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 13 days ago.)

Is Catalyst Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Catalyst Pharmaceuticals stock to perform well in the short-term.

Current score: 3.978

Remember To Visit Our YouTube Channel